Institut für Pharmakologie und Klinische Pharmazie, Fachbereich Pharmazie, Philipps-Universität Marburg, D-35032 Marburg, Germany.
J Biol Chem. 2013 Apr 12;288(15):10792-804. doi: 10.1074/jbc.M113.453522. Epub 2013 Feb 19.
Small conductance calcium-activated potassium (SK2/K(Ca)2.2) channels are known to be located in the neuronal plasma membrane where they provide feedback control of NMDA receptor activity. Here, we provide evidence that SK2 channels are also located in the inner mitochondrial membrane of neuronal mitochondria. Patch clamp recordings in isolated mitoplasts suggest insertion into the inner mitochondrial membrane with the C and N termini facing the intermembrane space. Activation of SK channels increased mitochondrial K(+) currents, whereas channel inhibition attenuated these currents. In a model of glutamate toxicity, activation of SK2 channels attenuated the loss of the mitochondrial transmembrane potential, blocked mitochondrial fission, prevented the release of proapoptotic mitochondrial proteins, and reduced cell death. Neuroprotection was blocked by specific SK2 inhibitory peptides and siRNA targeting SK2 channels. Activation of mitochondrial SK2 channels may therefore represent promising targets for neuroprotective strategies in conditions of mitochondrial dysfunction.
小电导钙激活钾 (SK2/K(Ca)2.2) 通道已知位于神经元质膜中,在那里它们提供 NMDA 受体活性的反馈控制。在这里,我们提供证据表明 SK2 通道也位于神经元线粒体的内膜中。在分离的 mitoplasts 中的膜片钳记录表明,SK2 通道插入到内膜中,C 和 N 末端朝向膜间空间。SK 通道的激活增加了线粒体 K(+)电流,而通道抑制则减弱了这些电流。在谷氨酸毒性模型中,激活 SK2 通道可减轻线粒体跨膜电位的丧失,阻断线粒体裂变,防止促凋亡线粒体蛋白的释放,并减少细胞死亡。针对 SK2 通道的特异性 SK2 抑制肽和 siRNA 阻断了神经保护作用。因此,激活线粒体 SK2 通道可能是线粒体功能障碍情况下神经保护策略的有希望的靶点。